SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Qilian International Holding Group Limited QLI NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • CN • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Qilian International Holding Group Limited (QLI) 是一家制药 - 专科与仿制药公司，属于医疗保健行业, 目前交易价格为 $5.41. 其SharesGrow评分为 38/100, 表明较弱的投资特征， 7项中通过1项.

财务数据: 营收为 $46M, -0.2%/yr 平均增长. 净利润为 $8M (亏损), 增长率为 -308.7%/yr. 净利润率为 -16.7% (负值). 毛利率为 1.3% (-13.8 pp 趋势).

资产负债表: 总债务为 $577,850 对比 $43M 股东权益 (D/E比率 0.01, 保守). 流动比率为 5.18 (流动性强). 资产负债率为 1.1%. 总资产: $51M.

SharesGrow 7项标准细分: Value ?/100 (Fail), Growth 15/100 (Fail), Past 75/100 (Partial), Health 100/100 (Pass), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

QLI SharesGrow 评分概览

50/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

价值 0/100

估值 — P/E, PEG, Forward PEG

成长 15/100

财务数据 — 平均增长

过去 75/100

强劲 — 趋势

健康 100/100

资产负债表 — D/E比率, 流动比率为

护城河 0/100

毛利率为 + market cap

未來 0/100

分析师展望 — 为买入

收入 10/100

净利润率为

Scores derived from financial statements, analyst ratings, and balance sheet data.

评分明细 — QLI

No analyst coverage available for this stock.

QLI: -0.2%/yr 营收为, -308.7%/yr 净利润为平均增长. 较弱. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

QLI: 3 / 4 年盈利. 一般. Score = 3 / 4 × 100. ≥ 80 = Pass.

View details →

资产负债表 QLI: D/E比率 0.01 (保守), 流动比率为 5.18 (流动性强). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

No analyst coverage available for this stock.

QLI: 净利润率为 -16.7%. 负值. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

股票图表与统计

市场数据

52周区间1.7755-6.69

成交量330

30日平均成交量22.52K

市值$38.68M

Beta（1年）1.41

股份统计

EPS（TTM）-0.22

流通股数$35.75M

IPO日期2021-01-12

员工数298

首席执行官Chen Xin

财务亮点与比率

营收（TTM）$46.47M

毛利润$608.43K

EBITDA$-1.27M

净利润$-7.78M

营业利润$-2.61M

现金总额$22.42M

总负债$577.85K

净负债$-6.9M

总资产$51.26M

市盈率（P/E）-24.6

市销率（P/S）0.83

分析师预测

公司信息

国家CN

交易所NASDAQ Global Market

货币USD

ISINKYG7307E1070

股价走势

QLI

Qilian International Holding Group Limited ↗ · NASDAQ Global Market

Healthcare • Drug Manufacturers - Specialty & Generic

1.78 52周区间 6.69

其他人也在看

Regencell Bioscience Holdings Limited

Phibro Animal Health Corporation

ANI Pharmaceuticals, Inc.

Sihuan Pharmaceutical Holdings Group Ltd.

Collegium Pharmaceutical, Inc.

Aquestive Therapeutics, Inc.

Procaps Group S.A.

Silver Spike Investment Corp.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言